about
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicityA Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site ConcentrationsIn vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.Diurnal variation in P-glycoprotein-mediated transport and cerebrospinal fluid turnover in the brain.Online solid phase extraction with liquid chromatography-tandem mass spectrometry to analyze remoxipride in small plasma-, brain homogenate-, and brain microdialysate samples.Prediction of methotrexate CNS distribution in different species - influence of disease conditions.Predicting Drug Concentration-Time Profiles in Multiple CNS Compartments Using a Comprehensive Physiologically-Based Pharmacokinetic Model.Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice.Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat.Diurnal variation in the pharmacokinetics and brain distribution of morphine and its major metabolite.Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice.Fingerprints of CNS drug effects: a plasma neuroendocrine reflection of D receptor activation using multi-biomarker pharmacokinetic/pharmacodynamic modellingBlood-Based Biomarkers of Quinpirole Pharmacology: Cluster-Based PK/PD and Metabolomics to Unravel the Underlying Dynamics in Rat Plasma and BrainStructural aspects of antioxidant activity of flavonoidsEffect of dimethyl sulfoxide (DMSO) on the electrocardiogram (ECG) in freely moving male Balb/c miceA quantum chemical explanation of the antioxidant activity of flavonoidsInfluence of iron chelation on the antioxidant activity of flavonoids
P50
Q35872593-562CA15A-98EF-4438-A63C-21E2A49C3755Q39172795-0027754E-1F12-4056-AC47-552A352530ABQ40839217-45ECA1A2-9CA4-4906-A756-A3966BEFA680Q42091226-B0555683-B0CE-49F3-B549-9B4A217B1B1BQ43123242-013BB3F2-4AF1-4E01-956D-3585C8962F81Q46941535-86F08948-69A6-44ED-838E-CEDE5E1B9385Q47131961-01BB8249-0485-461C-9B5B-1A2CD84973DFQ47307495-84EDA313-A71A-4BFE-990A-25A1597048DEQ48378208-0E4DF286-3D1A-437C-BD42-281E8E88BAF2Q48432760-ED789C6F-6965-4B6C-AA3A-8168257B5EF4Q48788163-81710143-D51F-43BC-A1A8-C9372AE83F48Q50453540-A0E48E02-F4AC-4943-907B-BDA762340005Q58780116-29C26A20-34AA-48DC-8EB6-8DA086CF59C3Q64228219-FCD51C5E-2543-4928-AA6F-6B558EA4D867Q71294326-E1E1B0C9-EC51-42F4-9D0D-75EBCED37A92Q71817686-CD9D2DCF-FADC-44D1-BE54-EAA813E6EA55Q71850293-D9CDFDF3-FF12-40AD-BD45-F21812C054CCQ77425087-864EDC43-06C1-4789-A81C-26027B7F933B
P50
description
researcher
@en
name
D J van den Berg
@en
D J van den Berg
@nl
type
label
D J van den Berg
@en
D J van den Berg
@nl
prefLabel
D J van den Berg
@en
D J van den Berg
@nl
P106
P31
P496
0000-0002-2253-579X